BioLineRx Ltd (BLRX) Net margin 2023–2025
BioLineRx Ltd (BLRX) net profit margin by fiscal year — reported net income divided by reported revenue.
-171.7%FY2025 · since FY2023: -1262.8% → -171.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -171.7% | -139.8 pp |
| FY2024 | -31.9% | +1230.9 pp |
| FY2023 | -1262.8% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BLRX financial trends
BLRX RevenueBLRX Net incomeBLRX Gross profitBLRX Gross marginBLRX Operating incomeBLRX Operating marginBLRX Operating cash flowBLRX Free cash flowBLRX Capital expendituresBLRX Return on equityBLRX Stock buybacksBLRX Dividends paidBLRX Total assetsBLRX Total liabilitiesBLRX Shareholders’ equityBLRX overview →